Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Biostar Microtech International's Days Sales Outstanding for the
three
months ended in Jun. 2026 was 33.46.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Biostar Microtech International's liquidation value for the
three
months ended in Jun. 2026 was NT$1,833 Mil.
Biostar Microtech International (TPE:2399) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Biostar Microtech International's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:
2. In Ben Graham's calculation of liquidation value, Biostar Microtech International's accounts receivable are only considered to be worth 75% of book value:
Biostar Microtech International's liquidation value for the quarter that ended in Jun. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biostar Microtech International Change In Receivables Related Terms
Biostar Microtech International Change In Receivables Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Biostar Microtech International Change In Receivables Chart
Biostar Microtech International Change In Receivables Calculation
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$32 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Receivables of NT$32 Mil mean?
Biostar Microtech International (TPE:2399) has a Change In Receivables of NT$32 Mil as of Jun. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Biostar Microtech International and its competitors.
Is Biostar Microtech International's Change In Receivables too high?
Biostar Microtech International's current Change In Receivables is NT$32 Mil. Overall, Biostar Microtech International has a GF Score™ of 55/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Biostar Microtech International's Change In Receivables compare to DELL and ANET?
Biostar Microtech International's Change In Receivables of NT$32 Mil can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Hardware company?
A good Change In Receivables depends on the Hardware industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Biostar Microtech International and its competitors. Biostar Microtech International's current Change In Receivables is NT$32 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biostar Microtech International stock overvalued right now?
Based on GuruFocus' analysis, Biostar Microtech International (TPE:2399) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$18.57, compared to a current price of NT$47.90 — trading 157.9% above its estimated fair value. The current Change In Receivables is NT$32 Mil. Biostar Microtech International's overall GF Score™ is 55/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Biostar Microtech International (TPE:2399), the current Change In Receivables is NT$32 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biostar Microtech International (TPE:2399) Overvalued in 2026?
Based on GuruFocus' analysis, Biostar Microtech International stock appears to be overvalued.
The current stock price of NT$47.90 is trading 157.9% above its estimated GF Value™ of NT$18.57.
GuruFocus considers Biostar Microtech International to be Significantly Overvalued.
Key valuation signals for TPE:2399:
Change In Receivables: NT$32 Mil
GF Value™: NT$18.57 vs. price of NT$47.90 (157.9% above fair value)
No single metric tells the full story. See the TPE:2399 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biostar Microtech International Corp is engaged in the manufacturing and selling of computer motherboards, industrial computers, and other computer peripheral products. The company's offerings include Industrial computers, motherboards, graphics cards, solid-state drives, memory, and other Peripheral equipment. Its reportable segments are: i) Asia-Pacific Operating Segment: Manufacture of computer mainboards, industrial computers and display cards, and sale of electronic products in the Asia-Pacific area, ii) America Sales Segment: Sale of electronic products in the Americas, and iii) Europe Sales Segment: Sale of electronic products in Europe. The majority of the company's revenue is derived from the Asia-Pacific Operating Segment.
55GF Score
Get the complete analysis for TPE:2399
Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:2399 has been successfully added to your 
